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1. Introduction  
Euphorbia is a genus of plants belonging to the family Euphorbiaceae. Botanist and 
taxonomist Carl Linnaeus assigned the name Euphorbia to the entire genus in the physician's 
honor. Euphorbia hirta is a very popular herb amongst practitioners of traditional herb 
medicine, widely used as a decoction or infusion to treat various ailments including 
intestinal parasites, diarrhoea, peptic ulcers, heartburn, vomiting, amoebic dysentery, 
asthma, bronchitis, hay fever, laryngeal spasms, emphysema, coughs, colds, kidney stones, 
menstrual problems, sterility and venereal diseases. Moreover, the plant is also used to treat 
affections of the skin. In this chapter we explore those investigations related to their 
pharmacological activities (see the section 2.2). 
2. Euphorbia hirta  
2.1 Chemical Composition of Euphorbia hirta 
Phytochemical analysis of Euphorbia hirta (E. hirta) revealed the presence of reducing sugar, 
alkaloids, flavonoids, sterols, tannins and triterpenoids in the whole plant. Some of them are 
well known to possess biological activities (as shown in table 1). 
2.1.1 Flavonoids 
Epidemiological studies have revealed that polyphenols, including flavonoids, provide a 
significant protection against development of several chronic diseases such as 
cardiovascular diseases, cancer, diabetes, infections, aging, and asthma. Two flavonoids 
have been isolated from E. hirta, namely quercitrin and myricitrin (Johnson et al, 1999; Chen, 
1991). In general, flavonoids have been reported to possess several proven medicinal 
properties including antioxidant (Kandaswami & Middleton, 1994), anti-allergic (Singh et al, 
2006), antiinflammatory component of asthma (Miller, 2001) and antidiarrheal activity 
(Galvez et al, 1993; Mallavadhani et al, 2002). Many of the biological actions of flavonoids 
have been shown to attribute to their antioxidant properties, either through their reducing 
capacities or as a result of their possible influence on intracellular redox status (Williams et 
al, 2004). Flavonoids can also interact selectively within the mitogen-activated protein 
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(MAP) kinase signalling pathway, thereby existing antiinflammation (Lee, 2011) and anti-
cancer activity (Ding et al, 2010).  
2.1.2 Sterols 
Sterols were isolated from E. hirta and chemically characterized as cycloarternol, 24-
methylene-cycloarternol, ┚-sitosterol, euphorbol hexacozonate, 1-hexacosanol, tinyaloxin, 
campesterol and stigmasterol (Atallah and Nicholas, 1972; Galvez et al, 1993; Johnson et al, 
1999). The compounds 24-methylene-cycloartenol and ┚-sitosterol have also been found to 
exert significant and dose-dependent anti-inflammatory effects, when treating acetate-
induced ear inflammation (Martinez-Vazquez et al, 1999). 
2.1.3 Tannins  
Tannins are not widely known for their anti-inflammatory potential. E. hirta possesses a few 
such chemicals. Phytochemicals work synergistically, however, and therefore these tannins 
may assist in the anti-inflammatory action of the plant. E. hirta presents three hydrolysable 
tannins, namely, dimeric hydrolysable tannin, euphorbin E and the dimeric 
dehydroellagitannins, euphorbin A and euphorbin B (Yoshida et al, 1990). The following 
tannins from the leaves of E. hirta were also isolated by using physicochemical and 
spectroscopic methods: gallic acid, 2,4, 6-tri-O-galloyl-D-glucose and 1,2,3,4, 6-penta-O-
galloyl-┚-D-glucose as well as the quinic acid ester, 3,4-di-O-galloylquinic acid (Chen 1991).  
2.1.4 Triterpenoids 
Research has shown that triterpenoids possess anti-inflammatory properties. The triterpenes 
┙-amyrin, ┚-amyrin, taraxerone (EH-1), taxerol as well as ┚-amyrin acetate have been 
identified from E. hirta (Martinez-Vazquez et al, 1999; Pinn, 2001; Mukherjee et al, 2004). 
Extracts of the plant were found to contain ┚-amyrin, which displayed a significant and dose 
dependent anti-inflammatory activity against acetate-induced ear inflammation (Martinez-
Vazquez et al, 1999) or LPS-induced inflammatory model (Shih et al, 2010). Two additional 
triterpenoids, namely, taraxerone and 11┙, 12┙-oxidotaraxerol, have also been found in E. 
hirta. These compounds induce both antibacterial and antifungal effects, as tested against 
fourteen pathogenic bacteria (Abu-Sayeed et al, 2005). 
2.2 Pharmacological effects of Euphorbia hirta 
2.2.1 Effects of E. hirta on GI system 
Protective effect of E. hirta against antitubercular drug-induced cytotoxicity was observed in 
freshly isolated hepatocytes. Antitubercular drug intoxication alters liver function by 
affecting aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, lactate 
dehydrogenase, triacylglycerol, cholesterol, total protein, albumin, total and direct bilirubin. 
A dose-dependent increase in percent viability was obtained when antitubercular drug 
exposed HepG2 cells were treated with different concentrations of alcoholic extract of E. 
hirta (125, 250, 500 and 1000 mg/mL). The effectiveness of liver protection was comparable 
to a standard hepatoprotective drug silymarin (Brindha et al, 2010). The antihepatotoxic 
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effect of E. hirta extracts were also evaluated in experimental models of liver injury in rats 
induced by CCL4 or paracetamol (Tiwari et al, 2011). Carbon tetrachloride and paracetamol 
are known to cause liver damage (Recknagel, 1983; James et al., 2003). When administered to 
rats, they act by inducing oxidative damages to liver cells which leads to cellular necrosis. E. 
hirta exhibited a 70 and 80% hepatoprotection compared to the 80 and 90% one exhibited by 
silymarin in CCL4 or paracetamol-injured rats, respectively. The extract E. hirta was 
demonstrated effectively in protecting the liver from toxic hepatitis. 
 
Components Chemicals Possible biological 
function 
References 
Flavonoids Quercitrin; Myricitrin  Antioxidation; 
Anti-allergy; 
Antibacterial activity; 
Molluscicidal activity; 
anti-diarrheal activity 
Galvez et al, 1993; 
Kandaswami & 
Middleton, 1994;  
Mallavadhani et al, 
2002; Singh et al, 2005;  
Singh et al, 2006; 
Park & Lee, 2006; 
Sudhakar et al, 2006; 
Rajeh et al, 2010; Ding 
et al, 2010; Lee, 2011 
Sterols  Cycloarternol;  
24-methylene-
cycloarternol;  
┚-sitosterol;  
euphorbol 
hexacozonate;  
1-hexacosanol; 
tinyaloxin; campesterol; 
stigmasterol 
anti-inflammatory 
effects 
Martinez-Vazquez et 
al, 1999 
Tannin  euphorbin E; euphorbin 
A; euphorbin B;  
gallic acid; 2,4,  
6-tri-O-galloyl-D-
glucose;  
1,2,3,4, 6-penta-O-
galloyl-┚-D-glucose; 3,4-
di-O- 
galloylquinic acid 
anti-inflammatory 
activity 
Yoshida et al, 1990; 
Chen 1991 
Triterpenoids  ┙-amyrin;  
┚-amyrin;  
taraxerone;  
taxerol; 
┚-amyrin acetate; 
taraxerone;  
11┙, 12┙-oxidotaraxerol 
anti-inflammatory 
activity; 
anti-pruritic activity;  
antidiabetic activity; 
antimicrobial activity 
Martinez-Vazquez et 
al, 1999; Pinn, 2001; 
Mukherjee et al, 2004; 
Abu-Sayeed et al, 
2005; Park & Lee, 
2006; Shih et al, 2010 
Table 1. Chemical compounds isolated from Euphorbia hirta. 
www.intechopen.com
 
Drug Discovery Research in Pharmacognosy 
 
168 
Aqueous leaf extract of E. hirta was shown to decrease the gastrointestinal motility in 
normal rats and decreased the effect of castor oil-induced diarrhoea in mice (Hore et al, 
2006; Galvez et al, 1993). The anti-diarrheal activity of E. hirta was also effective in 
arachidonic acid- and prostaglandin E2-induced diarrhoea (Galvez et al, 1993). Quercetin-3-
O-β-D-rhamnoside, a flavonoid, was found to be the active component with anti-diarrheal 
activity (Galvez et al, 1993; Mallavadhani et al, 2002).  
2.2.2 Effects of E. hirta on analgesic, antipyretic and anti-inflammatory actions 
E. hirta exists a dose-dependent analgesic action against chemical (writhing test) and thermic 
(hot plate test) stimuli from the doses of 20 and 25 mg/kg. This analgesic action was 
inhibited by pretreatment of naloxone, a specific morphinic antagonist compound. 
Therefore, it exerts central analgesic properties. In addition, E. hirta was effectively against 
acute pain in carrageenan-induced edema model (Lanhers et al, 1991). An antipyretic 
activity was obtained at the sedative doses of 100 and 400 mg/kg, on the yeast-induced 
hyperthermia (Lanhers et al, 1991).  
Antiinflammatory effects of E. hirta were shown in 12-o-tetradecanoyl phorbol acetate-
induced ear edema (Martinez-Vazquez et al, 1999; Lanhers et al, 1991). Although E. hirta was 
ineffective in Freund's adjuvant-induced rheumatoid arthritis model, it reduced the 
inflammatory hyperalgia of rheumatoid arthritis (Lanhers et al, 1991). The molecular 
pharmacology basis of this anti-inflammatory effect is revealed in an established 
inflammation model in lipopolysaccharide (LPS)-activated macrophages (fig 1). In the 
concentration range without showing cytotoxicity, E. hirta produced a remarkable anti-
inflammatory effect via its active component of beta-amyrin and showed a dose-related 
inhibition against LPS-induced NO production (Camuesco et al, 2004; Comalada et al, 2005; 
Shih et al, 2010). The extract of E. hirta and beta-amyrin are able to block most of the iNOS 
protein functions and NO induction (fig 2). The extract of E. hirta and beta-amyrin were not 
as potent as Indomethacin in preventing LPS-induced PGE2 production (Shih et al, 2010). 
This indicated that the extract of E. hirta and its active component, beta-amyrin, may have 
less gastrointestinal adverse effect than indomethacin does. The extract of E. hirta and its 
component beta-amyrin could therefore be new selective NO inhibitors with great potential 
in treating endotoxin-induced inflammation.  
2.2.3 Inhibition of allergic reactions and asthma by E. hirta 
E. hirta has been used to treated asthma as a folk medicine (Watanabe et al, 2005). E. hirta 
functions for the treatment of asthma is probably through synergistic anti-inflammatory 
and antioxidant activities of especially the flavonoids, sterols and triterpenoids (Park & 
Lee, 2006). Asthma has long been associated with chronic inflammation and an overall 
increase in reactive groups and oxidative stress (Nadeem et al, 2003). E. hirta also existed 
significant activity to prevent early and late phase allergic reactions and thereby asthma. 
E. hirta reduced asthma attack has been shown as effective as corticosteroid did in the 
BALB/c asthmatic mouse mode (Ekpo & Pretorius, 2008). The possible active component 
of E. hirta is thought to be Quercitrin. E. hirta ethanol extract significantly prevented 
eosinophil accumulation and eosinophil peroxidase activity and reduced the protein 
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content in bronchoalveolar lavage fluid in a 'mild' model of asthma (Singh et al, 2006). 
Taken together, E. hirta is a very potent herb medicine in treatment of asthma. Ethanol 
extract of E. hirta has also been shown to inhibit polysorbate 80-induced degranulation of 
isolated peritoneal mast cells in vitro. Thus anti-inflammatory activity of E. hirta could be 
attributed to mast cell membrane stabilization, thereby inhibiting the release of 
inflammatory mediators (Ramesh & Padmavathi, 2010). E. hirta ethanol extract also 
significantly inhibited dextran-induced rat paw edema, attenuated the release of 
interleukin-4 (IL-4) and augmented IFN-gamma in ovalbumin-sensitized mouse 
splenocytes (Singh et al, 2006). Anaphylactic allergic reaction is a life-threatening 
syndrome induced by the sudden systemic release of inflammatory mediators such as 
histamine and pro-inflammatory cytokines and can be elicited by various stimulators 
including compound 48/80 (N-methyl-p-methoxy-phenethylamine) and anti-IgE (Paul et 
al, 1993). Compound 48/80-induced mortality could also be reduced by E. hirta ethanol 
extract administration in Wistar rats (Youssouf et al, 2007). 
 
 
 
 
 
Fig. 1. Inflammatory model in LPS-activated Macrophage. 
Cytoplasm 
Nucleus 
NF-κB COX-2 
iNOS 
COX-2 
PGE2 
INOS NO ONOO
- 
O2
.- 
LBP 
L
CD14 
LPS 
 IKK  
P P
IκB 
P50 P65 
TNF-α,IL-1,IL-6 
LPS 
M
TLR4
www.intechopen.com
 
Drug Discovery Research in Pharmacognosy 
 
170 
 
Fig. 2. Inhibition of E. hirta and β-amyrin on LPS-induced iNOS gene and protein expression. 
2.2.4 Burn wound healing of E. hirta  
Tissue damage from excessive heat, electricity, radioactivity or corrosive chemicals that 
destroy (denature) protein in the exposed cells is called a burn. Burns disrupt haemostasis 
because they destroy the protection afforded by the skin. They permit microbial invasion 
and infection, loss of body fluid and loss of thermoregulation. Various extracts of E. hirta 
exhibited antimicrobial activity against various microbes including those causing burn and 
wound infections like Pseudomonas aeruginosa and Staphylococcus aureus (Sudhakar et al, 
2006; Rajeh et al, 2010). Hence, E. hirta could be beneficial in the management of burn 
wounds. The ethanol extract of whole plant of E. hirta was screened for burn wound healing 
activity in rats as 2% W/W cream. The study was carried out based on the assessment of 
percentage reduction in original wound. E. hirta was showed significant burn wound 
healing activity (Jaiprakash et al, 2006). 
2.2.5 Effects of E. hirta on anti-oxidation 
Free radicals have been claimed to play an important role in affecting human health by 
causing several chronic diseases, such as cancer, diabetes, aging, atherosclerosis, 
hypertension, heart attack and other degenerative diseases (Raghuveer et al, 2009). These 
free radicals are generated during body metabolism. Exogenous intake of antioxidants can 
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help the body scavenge free radicals effectively. There is a noticeable interest in 
antioxidants, especially in those which can prevent the presumed deleterious effects of free 
radicals in the human body, and to prevent the deterioration of fats and other constituents 
of foodstuffs. In both cases, there is a preference for antioxidants from natural rather than 
from synthetic sources (Molyneux et al, 2004). At present, most of the antioxidants are 
manufactured synthetically. The main disadvantage with the synthetic antioxidants is the 
side effects in vivo (Ramamoorthy et al, 2007). Previous studies reported that butylated 
hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) accumulate in the body and 
result in liver damage and carcinogenesis (Jiangning et al, 2005). Phytochemical screening of 
E. hirta revealed the presence of several chemicals, including flavanoids, which may be 
responsible for its strong anti-oxidative activity (Basma et al, 2011). The anti-oxidant activity 
of E. hirta was comparable with that of ascorbic acid and found to be dose dependent 
(Basma et al, 2011).  
2.2.6 Antidiabetic and free radicals scavenging potential of E. hirta  
Diabetes mellitus is a metabolic disease characterized by hyperglycemia resulting from 
defects in insulin secretion, insulin action, or both. It is well documented that chronic 
hyperglycemia of diabetes is associated with long-term damage, dysfunction, and 
eventually the failure of organs, especially the eyes, kidneys, nerves, heart, and blood 
vessels. Daily treatment of ethanol and petroleum ether flower extracts of E. hirta for three 
weeks significantly reduced alloxan-induced hyperglycemia, triglycerides and cholesterol 
(Kumar et al, 2010). Other biochemical parameters such as serum creatinine, urea and 
alkaline phosphatase levels were also found to be decreased whereas total proteins were 
found to be increased after treatments. Both extracts of E. hirta have significant antioxidant 
activity compared to other well characterized, standard antioxidant systems. Free radical 
scavenging potential was assessed against DPPH. The reductive capabilities of extract were 
compared with ascorbic acid and BHA. The extract showed dose dependent reducing 
power. This additional antioxidative effect of E. hirta may provide extract benefit in 
preventing oxidative-induced complications in diabetic patients.  
2.2.7 Effects of E. hirta on anti-infection 
The antimicrobial activities of the methanol extracts of E. hirta leaves, flowers, stems and 
roots were evaluated against some medically important bacteria and yeast using the agar 
disc diffusion method (Sudhakar et al, 2006; Rajeh et al, 2010; Singh et al, 2011). Four 
Gram positive (Staphylococcus aureus, Micrococcus sp., Bacillus subtilis and Bacillus 
thuringensis), four Gram negative (Escherichia coli, Klebsiella pneumonia, Salmonella typhi and 
P. mirabilis) and one yeast (Candida albicans) species were screened. Inhibition zones 
ranged between 16-29 mm. Leaves extract inhibited the growth of all tested 
microorganisms with large zones of inhibition, followed by that of flowers, which also 
inhibited all the bacteria except C. albicans. The most susceptible microbes to all extracts 
were S. aureus and Micrococcus sp. Root extract displayed larger inhibition zones against 
Gram positive bacteria than Gram negative bacteria and had larger inhibition zones 
compared to stem extract. The lowest MIC values were obtained with E. coli and C. 
albicans, followed by S. aureus and P. mirabilis. All the other bacteria had MIC values of 
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100.00 mg/mL. Scanning Electron Microscopic (SEM) studies revealed that the cells 
exposed to leaf extract displayed a rough surface with multiple blends and invaginations 
which increased with increasing time of treatment, and cells exposed to leaf extract for 36 
h showed the most damage, with abundant surface cracks which may be related to final 
cell collapse and loss of function. Time-kill assay of C. albicans indicated a primarily 
fungicidal effect at 1- and 2-fold MIC. Therefore, methanol extract of E. hirta possessed a 
broad spectrum of antimicrobial activity against studied bacterial strains. However, its 
inhibitory effect on H. pylori effects was weak (Ndip et al, 2007). Interestingly, E. hirta was 
not found to be very effective for anti-fungal activity by others (Abu-Sayeed et al, 2005; 
Singh et al, 2011). Taken together, E. hirta can be used to discover new bioactive natural 
products that may serve as leads in the development of new pharmaceuticals.  
The antiretroviral activities of extracts of E. hirta were investigated in vitro on the MT4 
human T lymphocyte cell line. A dose-dependent inhibition activity was observed for HIV-
1, HIV-2 and SIV (mac251) all three viruses. Methanol extract was found to exert a higher 
antiretroviral effect than that of the aqueous extract (Gyuris et al, 2009).  
2.2.8 Effects of E. hirta on molluscicidal activity and Larvicidal activity 
Mosquito-transmitted diseases remain a major cause of the loss of human life worldwide 
with more than 700 million people suffering from these diseases annually (Taubes 1997). 
Mosquito-borne diseases have an economic impact, including loss in commercial and labor 
outputs, particularly in countries with tropical and subtropical climates; however, no part of 
the world is free from vector-borne diseases (Fradin and Day 2002). Larvicidal activity of E. 
hirta has been found in petroleum ether extract with LC50 value 272.36 ppm (Abdul 
Rahuman et al, 2008).  
Many aquatic snails act as vectors for the larvae of trematodes and thereby, cause a number 
of diseases (Bali et al., 1986). Two diseases carried by aquatic snails, schistosomiasis and 
fascioliasis, cause immense harm to man and his domestic animals. The freshwater vector 
snail Lymnaea acuminata is the intermediate hosts of Fasciola hepatica and Fasciola gigantica 
(Hyman, 1970). Which caused endemic fascioliasis in sheep, cattle, goat and others 
herbivorous animal. Aqueous stem bark and leaf extracts of plant E. hirta have potent 
molluscicidal activity. Sub-lethal doses (40% and 80% of LC50) of aqueous stem bark and 
leaf extracts of this plant also significantly alter the levels of total protein, total free amino 
acid, nucleic acids (DNA and RNA) and the activity of enzyme protease and acid and 
alkaline phosphatase in various tissues of the vector snail Lymnaea acuminata in time and 
dose dependent manners (Singh et al, 2005).  
2.2.9 Immunostimulant effect of E. hirta in aquaculture 
E. hirta leaves have been used in aquaculture to protect fish from bacterial infection. 
Aquaculture is one of the fastest growing food-producing fields in the world, with an 
annual average growth rate of 6.9% per year since 1970 and this sector contributed about 
36% of the total global fisheries production in the year 2006 (FAO, 2009; Mohanty & Sahoo, 
2010). Infectious diseases are a major problem in aquaculture, causing heavy loss to fish 
farmers. Immunostimulants increase resistance to infectious diseases by enhancing both 
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specific and nonspecific defence mechanisms. The use of immunostimulants in fish culture 
is a promising new development in the field (Logambal et al., 2000; Dügenci et al., 2003; 
Rairakhwada et al., 2007). Pseudomonas fluorescens Flügge (Pseudomonadaceae) is an 
opportunistic bacterial fish pathogen of the freshwater ecosystem, associated with septic 
and ulcerative condition, necrosis of internal organs, external lesions, loss of pigmentation, 
and so on (Saharia & Prasad, 2001). The leaf extracts of E. hirta administered through the 
diet enhanced the nonspecific defence mechanism in terms of increased number of activated 
neutrophils and enhanced the serum lysozyme activity (secreted from active macrophages) 
in Cyprinus carpio Linn. The immunological competence was developed earlier on the plant 
leaf extract fed fish (on 5th day) than the control fish (on 10th day) after infection with the 
pathogen. In addition, the extract also exhibited potent antibacterial activity (Pratheepa1 
and Sukumaran, 2011). Immunostimulatory activity of E. hirta was also found to enhance in 
vitro phagocytosis of neutrophils and macrophages (Ramesh and Padmavathi, 2010).  
2.2.10 Effects of E. hirta on anti-anxiety 
Stress is increasingly recognized as the precipitant of several psychiatric illnesses including 
anxiety and depression (McEwen, 2000). When rats subjected to chronic immobilization 
stress (CIS) or forced swim stress (FSS) showed anxiety in the elevated plus maze (EPM) and 
the open field test (OFT) (Anuradha et al., 2008; Govindarajan et al., 2006; Vyas et al., 2002). 
In addition to anxiety, stress is also known to produce learning and memory deficits. For 
example, chronic stress impaired learning in the T-maze and radial arm maze (Ramkumar et 
al., 2008; Srikumar et al., 2006, 2007) or in other paradigms such as the Barnes maze and 
Morris water maze (Bodnoff et al., 1995; McLay et al., 1998). The dopaminergic and 
cholinergic neurotransmitter systems have been shown to be involved in mediating the 
stress induced deficits (Srikumar et al., 2006, 2007). CIS increased the acetylcholinesterase 
(AChE) activity in the frontal cortex, hippocampus, and septum, while E. hirta treatment 
brought it to normal levels. FSS increased the AChE activity only in the septum, and E. hirta 
treatment marginally normalized this change. Chronic stress not only induces impairment 
of learning and memory but also precipitates several affective disorders including 
depression and anxiety. Sedative properties of aqueous extract of E. hirta have been 
confirmed at high dose (100 mg of dried plant/kg) by showing a decrease of behavioral 
parameters measured in non-familiar environment tests (activitest and staircase test). For 
anti-conflict effects appeared at lower doses (12.5 and 25 mg of dried plant/kg) by revealing 
an enhancement of behavioral parameters measured in the staircase test and in the 
light/dark choice situation test (Lanhers et al, 1990). Anxiolytic property of E. hirta was also 
demonstrated in chronically stressed rats subjected to EPM and OFT (Anuradha et al, 2008). 
E. hirta treatment showed marked anti-anxiety activity in CIS rats. Co-treatment of rats with 
flumazenil, bicuculline or picrotoxin resulted in a significant reduction of anxiolytic effect of 
E. hirta indicating that its actions are mediated through GABAA receptor-benzodiazepine 
receptor-Cl channel complex. Acetylcholine and the cholinergic system are also known to 
involve in anxiety. Further study showed that anxiolytic effects of E. hirta in rats subjected to 
CIS was due to suppression of CIS-induced AChE activity in the frontal cortex, 
hippocampus, and septum brain regions (Anuradha et al, 2010). Together with GABA-
mimic effect and AChE reducing effect may explain the anxiolytic activity of E. hirta.  
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2.2.11 Effects of E. hirta on renal system 
Dickshit (1934) first reported the presence of a toxic principle in E. hirta that depressed the 
cardiovascular system with a resulting fall in blood pressure. The alcoholic and aqueous 
extracts of this plant have also been shown to depress the blood pressure of the dog 
(Hazleton and Hellerman, 1954). E. hirta is locally used to treat numerous diseases, 
including hypertension and edema in Africa (Khan et al., 1980). Diuretic effect of the E. hirta 
leaf extracts were assessed in rats using acetazolamide and furosemide as standard diuretic 
drugs. The water and ethanol extracts (50 and 100 mg/kg) of the plant produced time-
dependent increase in urine output. Regarding the secretion of electrolytes, the ethanol 
extract of E. hirta increased the excretion of HCO3-, decreased the loss of K+ and had little 
effect on renal removal of Na+. Whereas, the water extract increased the urine excretion of 
Na+, K+ and HCO3- that was similar to acetazolamide (Johnson et al, 1999).  
The renin–angiotensin system plays a vital role in the maintenance of vascular tone and 
peripheral resistance. Renin produced from the juxtaglomerular apparatus of the kidney 
splits angiotensinogen to produce the inactive decapeptide angiotensin I. The latter is then 
converted to the powerful octapeptide vasoconstrictor, angiotensin II by the action of 
angiotensin converting enzyme (ACE). ACE inhibitors are important agents for treating 
hypertension and congestive heart failure (Opie, 1992). E. hirta extract possessed compounds 
with potent ACE inhibitory activities. A dose of 500 mg crude extract expressed about 90% 
inhibition of the enzyme action. The study also revealed that the most active ACE inhibitory 
compounds were present in the medium polar (chloroform extract) and very polar 
(methanol and water) fractions. Extract of E. hirta (10 mg/100 mg body weight) also 
possessed anti-dipsogenic activities (Williams et al, 1997). Both diuresis and ACE inhibition 
effects of E. hirta may explain its antihypertensive effects.  
3. Conclusion 
Although E. hirta has been used wildly to treat various diseases in many countries, most of 
the involved molecular mechanisms have not been fully explored. However, the 
pharmacological mechanisms of E. hirta in asthma attacks and hypertension were relatively 
clear. The former can be due to its potent anti-inflammatory and anti-oxidative activities. 
The later may work through its actions of diuretic activity and ACE inhibition. For 
anxiolytic effects of E. hirta is thought to be mediated through GABAA-mediated Cl channel 
as well as AChE reduction. The anti-infection of E. hirta is due to its direct bactericidal 
activity. Antiinflammatory and antioxidative activities of E. hirta can also be expected to use 
in treating scald, preventing sepsis or other chronic inflammatory diseases. In overall, there 
are still many clinical applications of E. hirta remained to be investigated for their molecular 
mechanisms. 
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